12/18/2024 4:10 PM | Cara Therapeutics (Subject) Vifor Ltd (0001675217) (Filed by)
| Form SCHEDULE 13D/A | |
12/18/2024 3:26 PM | Cara Therapeutics (Filer)
| Form S-4 Registration statement under Securities Act of 1933 | |
12/18/2024 6:23 AM | Cara Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2024 6:25 AM | Cara Therapeutics (Subject)
| Form 425 | |
11/22/2024 3:09 PM | Cara Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2024 3:51 PM | Cara Therapeutics (Issuer) Posner Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/30/2024 3:21 PM | Cara Therapeutics (Subject) Vifor Ltd (0001675217) (Filed by)
| Form SC 13D | |
|
08/01/2024 3:15 PM | Cara Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/08/2024 3:32 PM | BlackRock Inc. (Filed by) Cara Therapeutics (Subject)
| Form SC 13G/A | |
06/12/2024 4:12 PM | Cara Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/06/2024 3:26 PM | Cara Therapeutics (Issuer) von Moltke Lisa (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 3:28 PM | Boudreau Helen M (Reporting) Cara Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/22/2024 3:07 PM | Cara Therapeutics (Filer)
| Form ARS | |
04/22/2024 3:08 PM | Cara Therapeutics (Filer)
| Form DEFA14A | |
04/12/2024 3:15 PM | Cara Therapeutics (Filer) Cara Therapeutics (Filer)
| Form PRE 14A | |
04/09/2024 3:21 PM | Cara Therapeutics (Issuer) Terrillion Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2024 3:22 PM | Cara Therapeutics (Issuer) Goncalves Joana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:16 PM | Cara Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/04/2024 3:24 PM | Cara Therapeutics (Issuer) Terrillion Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 3:13 PM | Cara Therapeutics (Issuer) Goncalves Joana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 3:19 PM | Cara Therapeutics (Issuer) Posner Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:50 PM | Bain Capital Life Sciences Opportunities III, LP (Filed by) Cara Therapeutics (Subject)
| Form SC 13G/A | |
02/12/2024 4:10 PM | Cara Therapeutics (Issuer) Posner Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 4:13 PM | Cara Therapeutics (Issuer) Goncalves Joana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 4:15 PM | Cara Therapeutics (Issuer) Maynard Ryan D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 4:16 PM | Cara Therapeutics (Issuer) Terrillion Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 3:32 PM | Cara Therapeutics (Issuer) Maynard Ryan D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 3:34 PM | Cara Therapeutics (Issuer) Terrillion Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 3:59 PM | Cara Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/29/2024 2:26 PM | BlackRock Inc. (Filed by) Cara Therapeutics (Subject)
| Form SC 13G/A | |
01/22/2024 3:19 PM | Cara Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |